SCHEMBL5096140

SCHEMBL5096140

Nc1ccc(C=CC(=O)c2cnc3ccccc3c2N2CCOCC2)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 6/20 0.47
KMT2A Q03164 6/20 0.47
SMN1; SMN2 Q16637 6/20 0.47
MAPT P10636 6/20 0.47
ALDH1A1 P00352 5/20 0.47
RAB9A P51151 5/20 0.47
NPC1 O15118 2/20 0.47
L3MBTL1 Q9Y468 2/20 0.47
MAOB P27338 1/20 0.45
PKM P14618 2/20 0.45
KDM4E B2RXH2 2/20 0.45
GRM5 P41594 1/20 0.43
PADI4 Q9UM07 1/20 0.41
GAA P10253 1/20 0.40
LMNA P02545 1/20 0.39
PTK2 Q05397 1/20 0.39
PPARD Q03181 1/20 0.39
PPARA Q07869 1/20 0.39
CYP1B1 Q16678 1/20 0.38
PSMD14 O00487 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5096143 0.82 MAOB (0.47) MEN1KMT2ASMN1; SMN2MAPTALDH1A1
SCHEMBL29643035 0.79 MEN1 (0.56) MEN1KMT2ASMN1; SMN2MAPTALDH1A1
SCHEMBL5093463 0.78 MEN1 (0.45) MEN1KMT2ASMN1; SMN2MAPTALDH1A1
SCHEMBL5090168 0.76 PPARD (0.62) MEN1KMT2ASMN1; SMN2MAPTALDH1A1
SCHEMBL5093454 0.70 MEN1 (0.45) MEN1KMT2ASMN1; SMN2MAPTALDH1A1
SCHEMBL5096124 0.70 MAPT (0.53) MEN1KMT2ASMN1; SMN2MAPTALDH1A1
SCHEMBL5101881 0.67 NCF1 (0.55) MEN1KMT2ASMN1; SMN2MAPTALDH1A1
SCHEMBL3830977 0.67 PTK2 (0.54) MEN1KMT2ASMN1; SMN2MAPTALDH1A1
SCHEMBL5090120 0.67 ALDH1A1 (0.50) MEN1KMT2ASMN1; SMN2MAPTALDH1A1
SCHEMBL30590433 0.64 MAPT (0.56) MEN1KMT2ASMN1; SMN2MAPTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080207608-A1 2-Propene-1-Ones As Hsp 70 Inducers TORRENT PHARMACEUTICALS LTD. (IN) 2008-08-28 US disclosed
EP-1748987-A2 2-PROPENE-1-ONES AS HSP 70 INDUCERS Torrent Pharmaceuticals Ltd (IN) 2007-02-07 EP disclosed
WO-2005097746-A2 2-PROPENE-1-ONES AS HSP 70 INDUCERS TORRENT PHARMACEUTICALS LTD (IN) 2005-10-20 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080207608-A1 2-Propene-1-Ones As Hsp 70 Inducers HSPB1, HSF1, HSPE1 MEN1 4052/4885KMT2A 4856/4885SMN1; SMN2 315/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.